A vitamin D level guides whether to correct a deficiency, since low vitamin D is associated with higher dementia risk in observational and genetic studies while supplementation trials for cognition have been null, so correcting a low level is reasonable and pushing it above normal is not
Combination-pathway research: Commonly studied with GLP-1 receptor agonists (e.g., semaglutide) to evaluate multi-hormone effects on appetite and metabolism
Reduces post-meal glucagon secretion similarly to amylins native function
When administered into the brain circulation and cerebrospinal fluid of mice, DSIP showed a significant, dose-dependent reduction in pain response in the tail-pinch and hot-plate tests
Reduced Cardiovascular Risk Hashimotos is associated with higher cholesterol and increased cardiovascular risk
We discuss the multi-agonists currently in clinical trials and how each new generation of these drugs improves their effectiveness